How should I evaluate and manage a patient with a blood pressure of 122/77 mm Hg and a heart rate of 123 beats per minute (tachycardia)?

Evaluation and Management of Tachycardia (HR 123 bpm) with Normal Blood Pressure (122/77 mmHg)

This patient requires immediate assessment of hemodynamic stability and symptoms, followed by a 12-lead ECG during tachycardia to differentiate the underlying rhythm before initiating any treatment. 1

Immediate Assessment

Determine Hemodynamic Stability

• This patient is hemodynamically stable based on the blood pressure of 122/77 mmHg, which indicates adequate perfusion. 2
• Signs of instability that would mandate immediate cardioversion include hypotension (systolic <90 mmHg), altered mental status, chest pain, acute heart failure, or shock—none of which are indicated by these vital signs alone. 1, 2
• A heart rate of 123 bpm falls below the threshold of 150 bpm, making it more likely that the tachycardia is secondary to an underlying condition (e.g., pain, anxiety, fever, dehydration, hyperthyroidism, anemia) rather than a primary arrhythmia. 2

Obtain 12-Lead ECG During Tachycardia

• A 12-lead ECG while the heart rate is elevated is essential to differentiate sinus tachycardia from supraventricular tachycardia (SVT), atrial flutter, atrial tachycardia, or ventricular tachycardia. 1
• Look for normal P-wave morphology identical to baseline with gradual onset/offset, which indicates physiologic sinus tachycardia. 1
• Abrupt onset, absent or retrograde P waves, and a regular narrow-complex rhythm at 150–250 bpm suggest paroxysmal SVT (AVNRT or AVRT). 1

Management Based on Rhythm Diagnosis

If Physiologic Sinus Tachycardia (Most Likely at HR 123 bpm)

• Do not treat the heart rate pharmacologically—sinus tachycardia at 123 bpm is typically a normal compensatory response. 1
• Identify and treat the underlying cause: assess for fever, pain, anxiety, dehydration, hyperthyroidism, anemia, pulmonary embolism, sepsis, or substance use (caffeine, stimulants). 1
• Allow the heart rate to normalize as the underlying condition resolves and catecholamines clear. 1

If Supraventricular Tachycardia (Less Likely but Possible)

First-Line: Vagal Maneuvers

• Attempt a modified Valsalva maneuver (patient supine, bearing down for 10–30 seconds to generate 30–40 mmHg intrathoracic pressure), which terminates SVT in approximately 43% of attempts. 1
• Alternative vagal techniques include carotid sinus massage (5–10 seconds steady pressure after confirming no carotid bruit) or ice-water facial immersion. 1
• Never apply pressure to the eyeball—this technique is dangerous and abandoned. 1

Second-Line: Adenosine

• If vagal maneuvers fail, administer adenosine 6 mg rapid IV push (over 1–2 seconds) via a large proximal vein, followed immediately by a 20 mL saline flush. 1
• If no conversion within 1–2 minutes, give 12 mg rapid IV push with saline flush; a second 12 mg dose may be administered (maximum cumulative dose 30 mg). 1
• Adenosine terminates 90–95% of AVNRT and 78–96% of AVRT episodes. 1
• Absolute contraindications: active asthma/bronchospasm, second- or third-degree AV block, sick sinus syndrome without a pacemaker. 1

Third-Line: Calcium-Channel Blockers or Beta-Blockers

• If adenosine fails or is contraindicated, administer IV diltiazem 15–20 mg over 2 minutes (conversion rate 64–98%). 1
• Alternative: IV verapamil 2.5–5 mg over 2 minutes or IV metoprolol 2.5–5 mg every 2–5 minutes (maximum 15 mg). 1
• Do not use calcium-channel blockers if ventricular tachycardia cannot be excluded, pre-excited atrial fibrillation is present, systolic heart failure is suspected, or the patient is hemodynamically unstable. 1

Blood Pressure Considerations

• A blood pressure of 122/77 mmHg is normal and does not require acute treatment. 3
• This reading is well below the threshold for hypertension (≥130/80 mmHg by ACC/AHA criteria) and does not contribute to the tachycardia. 1
• If this were an isolated elevated office reading, home blood pressure monitoring would be appropriate to exclude white-coat hypertension, but at 122/77 mmHg, no further blood pressure evaluation is needed. 4

Common Pitfalls to Avoid

• Do not treat physiologic sinus tachycardia with AV-nodal blockers—this can cause harm without addressing the underlying cause. 1
• Do not delay obtaining a 12-lead ECG during tachycardia—it is critical for differentiating SVT from sinus tachycardia and excluding ventricular tachycardia. 1
• Do not administer calcium-channel blockers or beta-blockers without first confirming the rhythm, as these agents can precipitate cardiovascular collapse if ventricular tachycardia or pre-excited atrial fibrillation is present. 1
• Do not assume tachycardia requires pharmacologic treatment—at 123 bpm with normal blood pressure, the most likely diagnosis is physiologic sinus tachycardia, which resolves with treatment of the underlying cause. 1, 2

Post-Evaluation Management

• If the rhythm is confirmed as sinus tachycardia and an underlying cause is identified and treated, no cardiac-specific therapy is required. 1
• If SVT is diagnosed and terminated, arrange cardiology referral for consideration of catheter ablation (94–98% single-procedure success) or long-term pharmacologic prophylaxis if episodes are recurrent. 1
• Continuous cardiac monitoring is essential immediately after any SVT conversion, as premature complexes can trigger rapid recurrence. 1